AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Telvas Beta 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telvas Beta 25 Tablet ER

CardioBeta 25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use enhances survival rates following a heart attack. Consistent blood levels are achieved by taking this medication with food daily, at the same time, as directed by your physician. Continued use is crucial, even if feeling well, as hypertension often presents no symptoms; premature discontinuation may worsen the condition. Lifestyle modifications – regular exercise, weight management, and a healthy diet – further assist blood pressure control. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, and electrolyte levels may be required. Inform your doctor of any liver or kidney issues, pregnancy, or breastfeeding before commencing treatment. Also disclose all other medications, especially those for hypertension or heart conditions.

Uses of Telvas Beta 25 Tablet ER

Managing elevated blood pressure

Major Benefits of Telvas Beta 25 Tablet ER:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Administer Telvas Beta 25 Extended-Release Tablet with food.

Common Side effects of Telvas Beta 25 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telvas Beta 25 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Telvas Beta 25 Tablet ER with a meal.

How Telvas Beta 25 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telvas Beta 25 ER tablets, provide sustained-release blood pressure control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telvas Beta 25 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmisartan 25 mg tablets (Telvas Beta 25) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmisartan 25 mg tablets are likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmisartan 25 mg tablets can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from driving if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Telmisartan 25 mg tablets (Telvas Beta 25 Tablet ER) pose no safety concerns for individuals with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Extended-release Telmisartan 25 mg tablets require careful administration in individuals with hepatic impairment. Dosage modification of Telmisartan 25 mg ER tablets may be necessary. Physician consultation is advised.

What if you forget to take Telvas Beta 25 Tablet ER :

Should you forget a Telvas Beta 25 Tablet ER dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Telvas Beta 25 Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication HEART

FAQs on Telvas Beta 25 Tablet ER

Indeed, Telvas Beta 25 Extended-Release Succinate tablets can induce dizziness. This side effect is often experienced upon standing after a period of lying down or sitting. To mitigate the risk of dizziness or syncope, change posture gradually from a recumbent or seated position.
Adopting a healthier lifestyle complements the effects of Telmisartan 25mg Extended-Release Tablets. Quitting smoking is crucial, as it significantly raises the risk of heart attack and stroke. Weight management is important; strive for a healthy weight if you are overweight or obese. A balanced diet rich in fruits and vegetables is recommended. Regular physical activity strengthens the heart and lowers the risk of heart attacks.
Continue taking Telvas Beta 25 Tablet ER as directed by your physician, even if you feel healthy. Abrupt cessation of Telvas Beta 25 Tablet ER can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Telvas Beta 25 Tablet ER
94
MRP 114
17% off